Search Results - A. O. Nedoshivin

Refine Results
  1. 1

    Angiotensin II and COVID-19. Secrets of interactions by A. O. Konradi, A. O. Nedoshivin

    Published 2020-05-01

    The article describes current data on the relationship of renin-angiotensin system and related drugs with the risk of COVID-19 infection and its outcomes. Analysis of the latest publications did not reveal association of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers w...

    Full description

    Get full text
    Article
  2. 2

    Recurrent ischemia after percutaneous coronary intervention by M. P. Malgina, A. O. Nedoshivin, B. B. Bondarenko

    Published 1970-01-01

    Aim. To study the incidence, time of development, and the main causes of recurrent myocardial ischemia after effective revascularization and percutaneous coronary intervention (PCI). Material and methods. The study included 108 patients PCI with coronary artery (CA) stenting (85 men (78,7 %), 23 wom...

    Full description

    Get full text
    Article
  3. 3

    Fitness club members: a “forgotten” target group for cardiovascular prevention? by A. E. Kutuzova, E. A. Kalinina, N. N. Petrova, A. O. Nedoshivin

    Published 2013-02-01

    Aim. To assess physical and mental health status of the fitness club members. Material and methods. The study included 156 fitness club members (125 women, mean age 31±1 years; 9 men, mean age 39±5,5 years) who were interviewed in order to assess their medical history and physical activity levels. A...

    Full description

    Get full text
    Article
  4. 4

    The role of beta-blockers in the treatment of hypertension in 2018 ESC/ESH guidelines by A. O. Konradi, L. G. Ratova, I. V. Emelyanov, A. O. Nedoshivin

    Published 2018-12-01

    Arterial hypertension (AH) is the most common non­infectious disease in the world and in Russia, associated with high cardiovascular morbidity and mortality. In August 2018, new guidelines for the diagnosis and treatment of patients with arterial hypertension were presented at the European Congress...

    Full description

    Get full text
    Article
  5. 5

    CURRENT STATE OF THE HEART VALVES POSTOPERATION MANAGEMENT by I. A. Gorlova, M. Yu. Omelchenko, T. I. Kazantseva, A. O. Nedoshivin, B. B. Bondarenko

    Published 2016-07-01

    The article summarizes a long-term follow-up experience on the patients underwent various operation types on cardiac valves, specifics of individualized approach at outpatient stage, reach of optimal hypocoagulation taking recent guidelines, prevention and early diagnostics of prosthesis-related com...

    Full description

    Get full text
    Article
  6. 6
  7. 7

    QUALITY OF LIFE AND PSYCHO-COGNITIVE CONDITION IN PATIENTS AFTER CORONARY ARTERY BYPASS GRAFT SURGERY by M. V. Goruleva, O. S. Ganenko, R. S. Коvaltcova, A. Kutuzova, N. N. Petrova, E. A. Demchemnko, A. O. Nedoshivin

    Published 2014-09-01

    Aim. To study psychic, cognitive status and life quality of petients underwentcoronary bypass grafting (CABG).Material and methods. Totally 81 patient with CHD studied (80% men, 20%women) with the age 56,3±1 y. o., underwent planned CABG. On 7–8th day afterCABG the 6-minute walk test (WT) was done a...

    Full description

    Get full text
    Article
  8. 8

    Effectiveness, safety, and endothelial function effects of atorvastatin lipid-lowering therapy in coronary heart disease patients undergoing percutaneous coronary intervention by M. P. Mal’gina, O. I. Ignatyeva, N. V. Moroshkina, Yu. V. Skorobogatova, A. O. Nedoshivin, O. A. Berkovich

    Published 2007-06-01

    Aim. To study lipid-lowering and pleiotropic atorvastatin effects on lipid metabolism, endothelial function, fibrinogen level in coronary heart disease (CHD) patients who underwent myocardial revascularization (percutaneous coronary intervention). Material and methods. The study included 40 CHD pati...

    Full description

    Get full text
    Article
  9. 9

    An observational study to assess the outcomes of treatment of patients with stable angina after planned percutaneous coronary intervention: baseline patient characteristics by L. G. Ratova, E. N. Parizhskaya, K. A. Kovaleva, A. O. Nedoshivin, O. D. Nemyatykh, V. V. Pulit, A. O. Konradi

    Published 2018-12-01

    Aim. To describe the characteristics of patients who were invited in observational, prospective study on a value-based approach to assess the outcomes of treatment of patients with stable coronary artery disease (CAD) by percutaneous coronary intervention (PCI).Material and methods. We analyzed the...

    Full description

    Get full text
    Article
  10. 10

    Results of the Russian Society of Cardiology survey "Chronic heart failure. Unsolved issues" by O. B. Irtyuga, S. V. Nedogoda, М. Yu. Sitnikova M.Yu., А. S. Galyavich, S. V. Villevalde, A. O. Nedoshivin, A. O. Konradi, E. V. Shlyakhto

    Published 2024-06-01

    Aim. To analyze the readiness of the professional medical community for changes in the classification and implementation of novel approaches to heart failure (HF) treatment based on an online survey.Material and methods. Anonymous online survey of physicians on the official website of the Russian So...

    Full description

    Get full text
    Article
  11. 11

    Clinical use of a fixed-dose combination of telmisartan and indapamide in hypertension. Expert Council resolution by A. O. Konradi, F. T. Ageyev, A. S. Galyavich, Yu. A. Karpov, Zh. D. Kobalava, Yu. V. Kotovskaya, S. V. Nedogoda, A. O. Nedoshivin, O. N. Tkacheva

    Published 2025-02-01

    The aim of the expert council "First star duo of telmisartan and indapamide in the Russian Federation", dedicated to the introduction of a new fixed-dose combination of telmisartan and indapamide (modified-release tablets) into clinical practice was to formulate an expert opinion on the po...

    Full description

    Get full text
    Article
  12. 12

    Practical efficacy and safety of Konsilar D24 in patients with hypertension: data from the KONSONANS program by A. O. Konradi, A. S. Galyavich, V. V. Kashtalap, Yu. M. Lopatin, N. P. Lyamina, S. V. Nedogoda, A. O. Nedoshivin, G. I. Nechaeva, L. G. Ratova, I. I. Shaposhnik

    Published 2021-10-01

    Aim. In practice, to evaluate the efficacy, safety and long-term adherence to therapy with a fixed-dose combination of ramipril/indapamide (Konsilar-D24) in patients with grade 1-2 hypertension (HTN) who have not achieved blood pressure (BP) control with prior therapy or have not taken antihypertens...

    Full description

    Get full text
    Article
  13. 13

    An open-label multicenter observational study (registry) of patients recovered from coronavirus disease 2019 (COVID-19) with involvement of the cardiovascular system or with baseli... by A. O. Konradi, S. V. Villevalde, D. V. Duplyakov, A. V. Kozlenok, O. V. Melnik, E. N. Mikhailov, O. M. Moiseeva, A. O. Nedoshivin, A. E. Soloveva, V. A. Fokin, A. N. Yakovlev, G. P. Arutyunov, Yu. N. Belenkov, E. V. Shlyakho

    Published 2021-02-01

    The potential impact on cardiovascular morbidity and mortality have become one of the most important issues of the coronavirus disease 2019 (COVID-19) pandemic. COVID-19 may be associated with more frequent development of acute cardiovascular complications, while patients with established cardiovasc...

    Full description

    Get full text
    Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20